Cleared Traditional

K935116 - EMIT IIC BARBITURATE ASSAY

K935116 is the FDA 510(k) clearance for EMIT IIC BARBITURATE ASSAY by Syva Co.. It is a Class 2 Toxicology device (product code DIS) cleared through the Traditional 510(k) pathway after a 483-day FDA review.

K935116 · Syva Co. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1995
Decision
483d
Days
Class 2
Risk

K935116 is an FDA 510(k) clearance for the EMIT IIC BARBITURATE ASSAY. Classified as Enzyme Immunoassay, Barbiturate (product code DIS), Class II - Special Controls.

Submitted by Syva Co. (San Jose, US). The FDA issued a Cleared decision on February 22, 1995 after a review of 483 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3150 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Toxicology submissions.

View all Syva Co. devices

Submission Details

510(k) Number K935116 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 1993
Decision Date February 22, 1995
Days to Decision 483 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
396d slower than avg
Panel avg: 87d · This submission: 483d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DIS Enzyme Immunoassay, Barbiturate
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3150
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DIS Enzyme Immunoassay, Barbiturate

All 60
Devices cleared under the same product code (DIS) and FDA review panel - the closest regulatory comparables to K935116.
ACS PHENOBARBITAL
K953021 · Ciba Corning Diagnostics Corp. · Dec 1995
AXSYM BARBITURATES II U
K951253 · Abbott Laboratories · May 1995
URINE BARBITURATES SCREEN FLEX(TM) REAGENT CARTRIDGE
K950137 · E.I. Dupont DE Nemours & Co., Inc. · Apr 1995
CX(TM) BARBITURATES(BARB) REAGENT FOR SYNCHRON CX SYST
K944075 · Beckman Instruments, Inc. · Dec 1994
CEDIA DAU BARBITURATE ASSAY
K945344 · Microgenics Corp. · Dec 1994
CEDIA DAU BARBITURATE ASSAY
K942436 · Microgenics Corp. · Aug 1994